Terry Fox New Frontiers Program Project Grants
The Terry Fox New Frontiers Program Project Grants is a long‐standing program involving the best cancer researchers in Canada. These programs support Canadian research teams exploring new frontiers in cancer research (i.e., breakthrough and transformative biomedical, clinical and translational research which may form the basis for innovative cancer prevention, diagnosis and/or treatment).
Terry Fox New Investigator Award
The Terry Fox New Investigator Award provides research operating grants to support future leaders as they develop their independent careers in cancer research. The award provides a single research grant of up to $450,000 for three years to investigators within the first five years of a first faculty-level appointment in Canada.
Engaged Research Grant
Partnership Engage Grants
These grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. The small-scale, stakeholder-driven partnerships supported through Partnership Engage Grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. In addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.
Resilient Health Systems for All - Concept Notes
Challenge Grants Call for Applications
The Challenge Grants program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a ‘challenge’) in cancer that is meaningful to people affected by or at risk of cancer. Applications from the four pillars of health research (i.e. biomedical; clinical; health services; and social, cultural, environmental and population health) are welcome. |
Deadline Dates:
Up to $18M is available in this competition to fund grants of up to $175k/yr over 3 years. For more information, please see https://cancer.ca/en/research/for-researchers/funding-opportunities/challenge-grants-24. |
TRANSCAN-3 Joint Transnational Call: Translational Research on Cancer Epigenetics
|
| For more information, please contact Jill Sherman at intl.research@lakeheadu.ca. |
ALS Canada-Brain Canada Discovery Grant Program 2023
Brain Canada and the ALS Society of Canada are pleased to announce the continuation of the Discovery Grant Program. The purpose of the 2023 Discovery Grant Program is to invest in the best possible projects that are focused on identifying causes of, or treatments for ALS and/or related neurological diseases, including primary lateral sclerosis, progressive muscular atrophy, and ALS/FTLD (frontotemporal lobar dementia), or research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management, and support to persons or families living with ALS.
Discovery Grants are designed to support teams of multiple investigators and especially encourage multidisciplinary teams with individuals from outside the field who can combine their expertise in novel or innovative ways.
The ALS Canada – Brain Canada Discovery Grant Program 2023 consists of two streams, which both consist of novel or innovative research approaches, supported by sound rationale and a feasible experimental plan, and maintain the high-risk/high-reward mindset:
Stream 1: Aimed at nurturing novel ideas looking to obtain preliminary data or to pursue ideas supported by very early data signals. Preliminary data may enhance competitiveness but is not necessarily required. Up to six awards of $125,000 will be awarded in this cycle.
Deadline for receipt of Applications: July 12, 2023 at 13:00 ET
